Search results
Zymergen was an American biotechnology company based in Emeryville, California. The company applies genomics and machine learning to research and design chemical producing genetically modified organisms. It claimed that its manufacturing process was safer and cheaper than traditional manufacturing, but was unable to demonstrate this.
Oct 19, 2022 · Today, we’re pleased to announce our completed acquisition of Zymergen. This is our largest acquisition to date! It’s expected to significantly enhance our platform by integrating strong automation and software capabilities as well as providing a wealth of experience across diverse biological engineering approaches.
Oct 13, 2021 · The company behind the ad was Zymergen, a California synthetic biology company that had just gone public with a market capitalization of $3 billion. Its three founders — Josh Hoffman, Zach ...
Jul 25, 2022 · Zymergen aimed to leave its well-publicized woes behind through a new-year transformation into a biotech. Now, the company has been picked up by Ginkgo Bioworks, which will look for “strategic ...
Jul 25, 2022 · Ginkgo Bioworks acquired biotechnology firm Zymergen, the synthetic biology companies announced Monday morning, marking the final act in Zymergen’s dramatic and brisk fall from grace.
Oct 19, 2022 · BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA ), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced that...
Zymergen | 31,531 followers on LinkedIn. Zymergen is now a part of Ginkgo Bioworks!
Jan 10, 2022 · By combining next-gen sequencing with proprietary machine learning and informatics, Zymergen’s platform transforms the search for structurally novel bioactive molecules from tedious screening...
Jul 25, 2022 · (RTTNews) - Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which...
Oct 19, 2022 · BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced that...
